Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Davis

Showing results (101-110 of 400) with videos related to

Pageof 40
Sort By:
Journal of the American Geriatrics Society|May 1, 1983
Neurotransmitter deficits in Alzheimer's disease: criteria for significanceB S Greenwald, R C Mohs, K L Davis
Advances in Neurology|January 1, 1990
Therapeutic trials using tacrine and other cholinesterase inhibitorsE R Gamzu, L J Thal, K L Davis
Life Sciences|September 28, 1981
Partial reversal of anticholinergic amnesia by choline chlorideR C Mohs, K L Davis, M I Levy
The American Journal of Psychiatry|November 1, 1984
A new rating scale for Alzheimer's diseaseW G Rosen, R C Mohs, K L Davis
The Journal of Nervous and Mental Disease|March 1, 1978
Single case study. Possible organophosphate-induced parkinsonismK L Davis, J A Yesavage, P A Berger
Journal of Animal Science|September 1, 1987
Breed differences in uterine and ovarian measurements in gestating swineK L Davis, O W Robison, V D Toelle
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2001
Abnormal kainate receptor expression in prefrontal cortex in schizophreniaJ H Meador-Woodruff, K L Davis, V Haroutunian
Psychopharmacology Bulletin|January 1, 1983
The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacyR C Mohs, W G Rosen, K L Davis
Life Sciences|October 16, 1978
Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidolK L Davis, L E Hollister, W C Fritz
Psychopharmacology Bulletin|October 1, 1982
Studies of plasma homovanillic acid as an index of brain dopamine functionK S Kendler, J Y Hsieh, K L Davis
Pageof 40

Showing results (101-110 of 400) with videos related to

Sort By:
Pageof 40
Journal of the American Geriatrics Society|May 1, 1983
Neurotransmitter deficits in Alzheimer's disease: criteria for significanceB S Greenwald, R C Mohs, K L Davis
Advances in Neurology|January 1, 1990
Therapeutic trials using tacrine and other cholinesterase inhibitorsE R Gamzu, L J Thal, K L Davis
Life Sciences|September 28, 1981
Partial reversal of anticholinergic amnesia by choline chlorideR C Mohs, K L Davis, M I Levy
The American Journal of Psychiatry|November 1, 1984
A new rating scale for Alzheimer's diseaseW G Rosen, R C Mohs, K L Davis
The Journal of Nervous and Mental Disease|March 1, 1978
Single case study. Possible organophosphate-induced parkinsonismK L Davis, J A Yesavage, P A Berger
Journal of Animal Science|September 1, 1987
Breed differences in uterine and ovarian measurements in gestating swineK L Davis, O W Robison, V D Toelle
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2001
Abnormal kainate receptor expression in prefrontal cortex in schizophreniaJ H Meador-Woodruff, K L Davis, V Haroutunian
Psychopharmacology Bulletin|January 1, 1983
The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacyR C Mohs, W G Rosen, K L Davis
Life Sciences|October 16, 1978
Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidolK L Davis, L E Hollister, W C Fritz
Psychopharmacology Bulletin|October 1, 1982
Studies of plasma homovanillic acid as an index of brain dopamine functionK S Kendler, J Y Hsieh, K L Davis
Pageof 40